Cargando…

Chromosomal Microarray Analysis versus Karyotyping in Fetuses with Increased Nuchal Translucency

We have carried out a retrospective study of chromosome anomalies associated with increased nuchal translucency (NT) in order to compare yield rates of karyotype, chromosome microarray analysis (CMA), and non-invasive prenatal testing (NIPT) in this condition. Presenting with increased NT or cystic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cicatiello, Rita, Pignataro, Piero, Izzo, Antonella, Mollo, Nunzia, Pezone, Lucia, Maruotti, Giuseppe Maria, Sarno, Laura, Sglavo, Gabriella, Conti, Anna, Genesio, Rita, Nitsch, Lucio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6473420/ https://www.ncbi.nlm.nih.gov/pubmed/30818867 http://dx.doi.org/10.3390/medsci7030040

Ejemplares similares

Clinical application of chromosomal microarray analysis in fetuses with increased nuchal translucency and normal karyotype
por: Su, Linjuan, et al.
Publicado: (2019)

Pregnancy outcomes of normal karyotype fetuses with increased nuchal translucency
por: Niroomanesh, Shirin, et al.
Publicado: (2023)

Overexpression of Chromosome 21 miRNAs May Affect Mitochondrial Function in the Hearts of Down Syndrome Fetuses
por: Izzo, Antonella, et al.
Publicado: (2017)

Incidence of major structural cardiac defects in fetuses with increased nuchal translucency and normal karyotype
por: Praprotnik, K, et al.
Publicado: (2013)

Increased nuchal translucency in fetuses with a normal karyotype—diagnosis and management: An observational study
por: Socolov, Demetra, et al.
Publicado: (2017)

Chromosomal microarray analysis versus noninvasive prenatal testing in fetuses with increased nuchal translucency
por: Wang, Chaohong, et al.
Publicado: (2022)

Targeting Mitochondrial Network Architecture in Down Syndrome and Aging
por: Mollo, Nunzia, et al.
Publicado: (2020)

Ultrasound and echocardiographic findings obtained in the second and third trimesters of gestation in fetuses with normal karyotype and increased nuchal translucency
por: Moczulska, Hanna, et al.
Publicado: (2013)

High Frequency of Fetal Loss in Fetuses With Normal Karyotype and Nuchal Translucency ≥ 3 Among the Iranian Pregnant Women
por: Abotorabi, Shokoh, et al.
Publicado: (2020)

The Distribution of Fetal Nuchal Translucency Thickness in Normal Korean Fetuses
por: Chung, Jin-Hoon, et al.
Publicado: (2004)

Ultrasonography of the nuchal translucency of healthy and abnormal English Bulldog fetuses
por: Pavan, Letícia, et al.
Publicado: (2021)

Prenatal whole‐exome sequencing in fetuses with increased nuchal translucency
por: Cao, Chunge, et al.
Publicado: (2023)

Prenatal Diagnostic Value of Chromosomal Microarray in Fetuses with Nuchal Translucency Greater than 2.5 mm
por: Zhang, Zhu, et al.
Publicado: (2019)

Prenatal Diagnosis of Fetuses With Increased Nuchal Translucency by Genome Sequencing Analysis
por: Choy, Kwong Wai, et al.
Publicado: (2019)

Analysis of copy number variation by sequencing in fetuses with nuchal translucency thickening
por: Lan, Liubing, et al.
Publicado: (2020)

Neurodevelopmental outcome at 2 years of corrected age in fetuses with increased nuchal translucency thickness and normal karyotype compared with matched controls
por: Buffin, R., et al.
Publicado: (2021)

Mitochondrial dysfunction in down syndrome: molecular mechanisms and therapeutic targets
por: Izzo, Antonella, et al.
Publicado: (2018)

Prenatal diagnosis and early childhood outcome of fetuses with extremely large nuchal translucency
por: Zhou, Hang, et al.
Publicado: (2023)

Chromosomally and Anatomically Normal Fetuses With Increased First Trimester Nuchal Translucency Conceived by ICSI
por: Niknejadi, Maryam, et al.
Publicado: (2015)

Increased nuchal translucency in children with congenital heart defects and normal karyotype—is there a correlation with mortality?
por: Kristensen, Rasmus, et al.
Publicado: (2023)

Prenatally diagnosed distal 16p11.2 microdeletion with a novel association with congenital diaphragmatic hernia: a case report
por: Genesio, Rita, et al.
Publicado: (2018)

Increased Nuchal Translucency and Pregnancy Outcome
por: Tahmasebpour, A, et al.
Publicado: (2012)

Fetal nuchal translucency scan in Nigeria
por: Oloyede, Olufemi Adebari, et al.
Publicado: (2014)

Chromosomal abnormalities and structural defects in fetuses with increased nuchal translucency at a Chinese tertiary medical center
por: Zhang, Huijing, et al.
Publicado: (2023)

Overexpression of the Hsa21 Transcription Factor RUNX1 Modulates the Extracellular Matrix in Trisomy 21 Cells
por: Mollo, Nunzia, et al.
Publicado: (2022)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
por: Bestwick, J P, et al.
Publicado: (2010)

Evaluation of Nuchal Translucency Measurement in First Trimester Pregnancy
por: Barati, Mojgan, et al.
Publicado: (2011)

Simplified protocol of nuchal translucency measurement: Is it still effective?
por: Kim, Sun Min, et al.
Publicado: (2013)

Distribution of nuchal translucency in antenatal screening for Down's syndrome
Publicado: (2010)

Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?
por: Kalem, Ziya, et al.
Publicado: (2019)

Congenital extracardiac venous system anomaly in two siblings with normal karyotype and increased nuchal translucency thickness: a case report
por: Takahashi, Yuko, et al.
Publicado: (2020)

Perinatal Outcomes in Foetuses with Increased Nuchal Translucency and Normal Karyotype: A Retrospective Cohort Study from the United Arab Emirates
por: Khair, Howaida, et al.
Publicado: (2023)

Prenatal diagnosis and perinatal outcomes of twin pregnancies disharmonious for one fetus with nuchal translucency above the 95th percentile
por: Wang, You, et al.
Publicado: (2023)

Detection of Fetal Abnormalities Based on Three Dimensional Nuchal Translucency
por: Lai, Khin Wee, et al.
Publicado: (2013)

The effect of progesterone use in the first trimester on fetal nuchal translucency
por: Namlı Kalem, Müberra, et al.
Publicado: (2018)

Clinical significance of nuchal translucency measurement in routine prenatal examination
por: Zhao, Xin-Rong, et al.
Publicado: (2021)

Effect of Exogenous Progesterone on Fetal Nuchal Translucency: An Observational Study
por: Bagde, Nilajkumar D, et al.
Publicado: (2022)

Nuchal translucency of 3.0‐3.4 mm an indication for NIPT or microarray? Cohort analysis and literature review
por: Petersen, Olav B., et al.
Publicado: (2020)

Isolated Increased Nuchal Translucency in First Trimester Ultrasound Scan: Diagnostic Yield of Prenatal Microarray and Outcome of Pregnancy
por: Stuurman, Kyra E., et al.
Publicado: (2021)

Editorial Comment on: H. Moczulska, K. Janiak, M. Słodki and M. Respondek-Liberska Ultrasound and echocardiographic findings obtained in the second and third trimesters of gestation in fetuses with normal karyotype and increased nuchal translucency
por: Mądry, Wojciech, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_n41tk685h1tv6c3le8ffvm3hqp